CORPORATE, SOCIAL AND ETHICAL POLICIES

Clinigen recognises the importance of balancing the interests of its customers, shareholders, employees, suppliers and the communities in which it operates. Management of the environmental and social issues that play a part in the business is a key factor in the Group’s strategy for success and in the practice of good corporate governance. With this in mind, the Group, through its management team and its experienced quality and regulatory department audit all suppliers and manufacturers regularly to ensure they reach the standards set and respond to any improvement requests we make of them.

The Group aspires to carry out its business to the highest ethical standards, treating employees, suppliers and customers in a professional, courteous and honest manner. Ethical standards are included in our audit schedule when reviewing our suppliers and manufacturers to check the standards they follow meet our expectations.

EMPLOYEES

The Group employs over 500 people in eight countries and is committed to a policy of equal opportunities in the recruitment, engagement and retention of employees. The multinational diversity of our team not only supports our global service offering but demonstrates our lack of barriers to employment. Employees are supported to undertake additional training, both internal and external, to develop their skills which are then often transferred across departments or enable promotion.

Age, colour, gender, disability, ethnic origin, national origin, marital status, sexual orientation, religious or political view is not seen as a barrier to employment and is evidenced by the Group’s diverse employment base. The Group would support employees if they were to become disabled whilst employed by the Group, and those employees would be retained where possible and training provided as required.

It is important we listen to our employees and understand their views on Clinigen as an employer. The Group operates a culture of open communication through a range of two-way mediums including: monthly employee representative staff forums; newsletters; and regular Group updates from the CEO, Deputy CEO and CFO. The strategic objectives of the Group are communicated to the employees through the monthly updates and at the annual all staff conference. The employees are encouraged to be a part of the Group’s success through share ownership and the Group’s employee share schemes.

The Group’s first employee engagement survey was held during the year and senior management take the findings of the survey seriously and will act appropriately.

We recognise the importance of diversity, including gender, at all levels of the company. The Group already has a strong female representation in both management and operational boards. On our management board, women comprise 33% of positions for the UK and 29% for our international operations. In addition, out of 308 employees in the UK, approximately 58% are female and approximately 29% of the senior managers in the UK are female. We continue to actively seek to recruit and advance women into our top management. In preparation for the introduction of mandatory gender pay gap reporting in 2016, Clinigen will proactively investigate and address gender pay gaps.

MODERN SLAVERY ACT

The Group fully supports aims of the Modern Slavery Act 2015 to eradicate human slavery and trafficking. In particular, the Group wishes to ensure that no child labour or servitude of any kind or human trafficking has been involved in the supply and distribution of products or services. This statement is made pursuant to Section 54, Part 6 of the Modern Slavery Act 2015 and sets out the steps the Company has taken to ensure that slavery and human trafficking is not taking place in our supply chains or in any part of our business. As we have expanded with the merger of Idis and Link, Clinigen has become a worldwide supplier and distributor of pharmaceutical products and services. As part of our initiative to identify and mitigate risk we have, or are in the process of putting in place, systems to:

  • Identify and assess potential risk areas in our supply chains
  • Mitigate the risk of slavery and human trafficking occurring in our supply chains
  • Monitor potential risk areas in our supply chains
  • Protect whistle blowers

The Group will continue to review the position by a process of contract reviews, third party audits and an ongoing monitoring of our partners within the supply chain.

COMMUNITY

Clinigen participates in local community projects that it feels are worthy and appropriate and encourages employees to get involved in local and national charitable events, as well as deciding where charitable donations are placed. An example of this is the League Managers Association, with whom we work to support local schools in their Football Association level coaching.

The Group has continued to support Foundation MEM over a number of years, which is a charity focusing on developing a better life for a village in Cameroon which is very close to some of our employees, and The Anthony Nolan Trust, a charity very relevant to Foscavir, the first product acquired in 2010.

Clinigen work alongside Patient Group Organisations in the MA division. We believe greater patient involvement in personal healthcare needs and also in the development of local and national healthcare provision is an important part of the future development of effective healthcare services. The Group made no political donations during the year (2015: £nil) and made charitable donations of £3k (2015: £15k).

HEALTH AND SAFETY

The Group recognises that health and safety has positive benefits to the organisation and that a commitment to a high level of safety makes good business sense. It also recognises that health and safety is a business function and must, therefore, continually improve, progress and adapt to change. To achieve this aim, appropriate levels of resource are allocated to ensuring a positive health and safety culture throughout the company. The Group approach to health and safety is based on the identification and control of risks. Adequate planning, monitoring and reviews of the health and safety Policy are carried out in line with our Safety Management System ('SMS') to ensure continual improvement to our health and safety standards.